1 Shin EC, "Taking the brake off T cells in chronic viral infection" 12 : 276-277, 2006
2 Jung-Ho Kim, "Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy" 대한면역학회 20 (20): 1-17, 2020
3 Se Jin Im, "Re-defining T-Cell Exhaustion: Subset, Function, and Regulation" 대한면역학회 20 (20): 1-19, 2020
4 Kyung Hwan Kim, "Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy" 대한면역학회 20 (20): 1-15, 2020
5 임선민, "Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives" 대한면역학회 20 (20): 1-14, 2020
6 Pardoll DM, "Immunology beats cancer : a blueprint for successful translation" 13 : 1129-1132, 2012
7 Postow MA, "Immune-related adverse events associated with immune checkpoint blockade" 378 : 158-168, 2018
8 Sharma P, "Immune checkpoint targeting in cancer therapy : toward combination strategies with curative potential" 161 : 205-214, 2015
9 Da-Sol Kuen, "IL-17-Producing Cells in Tumor Immunity: Friends or Foes?" 대한면역학회 20 (20): 1-20, 2020
10 Champiat S, "Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1" 23 : 1920-1928, 2017
1 Shin EC, "Taking the brake off T cells in chronic viral infection" 12 : 276-277, 2006
2 Jung-Ho Kim, "Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy" 대한면역학회 20 (20): 1-17, 2020
3 Se Jin Im, "Re-defining T-Cell Exhaustion: Subset, Function, and Regulation" 대한면역학회 20 (20): 1-19, 2020
4 Kyung Hwan Kim, "Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy" 대한면역학회 20 (20): 1-15, 2020
5 임선민, "Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives" 대한면역학회 20 (20): 1-14, 2020
6 Pardoll DM, "Immunology beats cancer : a blueprint for successful translation" 13 : 1129-1132, 2012
7 Postow MA, "Immune-related adverse events associated with immune checkpoint blockade" 378 : 158-168, 2018
8 Sharma P, "Immune checkpoint targeting in cancer therapy : toward combination strategies with curative potential" 161 : 205-214, 2015
9 Da-Sol Kuen, "IL-17-Producing Cells in Tumor Immunity: Friends or Foes?" 대한면역학회 20 (20): 1-20, 2020
10 Champiat S, "Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1" 23 : 1920-1928, 2017
11 Kim CG, "Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer" 30 : 1104-1113, 2019
12 Hye Won Lee, "Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity" 대한면역학회 20 (20): 1-15, 2020
13 Sejin Oh, "Far Beyond Cancer Immunotherapy: Reversion of Multi-Malignant Phenotypes of Immunotherapeutic-Resistant Cancer by Targeting the NANOG Signaling Axis" 대한면역학회 20 (20): 1-11, 2020
14 Hye Won Lee, "Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?" 대한면역학회 20 (20): 1-14, 2020
15 Seongju Jeong, "Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy" 대한면역학회 20 (20): 1-20, 2020
16 Juwhan Choi, "Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors" 대한면역학회 20 (20): 1-21, 2020
17 Schreiber RD, "Cancer immunoediting : integrating immunity's roles in cancer suppression and promotion" 331 : 1565-1570, 2011